Medtech InsightMay Health’s Ovarian Rebalancing Treatment Ovulation Rates Results from the ULTRA US and European feasibility trials showed May Health’s Ovarian Rebalancing is a promising treatment for women with e
In VivoBiopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede